Amgen reported strong financial results, exceeding expectations with increased revenue and earnings growth. The company raised its 2016 guidance and increased its dividend, reflecting confidence in future performance. Positive developments in their product pipeline and successful product launches suggest a positive short-term outlook for the stock.

[1]